BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38035113)

  • 21. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis.
    Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
    Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells.
    Di Pace AL; Pelosi A; Fiore PF; Tumino N; Besi F; Quatrini L; Santopolo S; Vacca P; Moretta L
    Oncoimmunology; 2023; 12(1):2221081. PubMed ID: 37304055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways.
    Teng R; Wang Y; Lv N; Zhang D; Williamson RA; Lei L; Chen P; Lei L; Wang B; Fu J; Liu X; He A; O'Dwyer M; Hu J
    J Immunol Res; 2020; 2020():4598476. PubMed ID: 33123602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3.
    Fang P; Xiang L; Chen W; Li S; Huang S; Li J; Zhuge L; Jin L; Feng W; Chen Y; Pan C
    Innate Immun; 2019 Feb; 25(2):99-109. PubMed ID: 30774011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
    Ni J; Zhou S; Yuan W; Cen F; Yan Q
    J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a
    Wang H; Zhang Y; Wu X; Wang Y; Cui H; Li X; Zhang J; Tun N; Peng Y; Yu J
    Front Immunol; 2018; 9():293. PubMed ID: 29593706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.
    Xie J; Liu M; Li Y; Nie Y; Mi Q; Zhao S
    Cell Mol Immunol; 2014 Sep; 11(5):495-502. PubMed ID: 24813230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17.
    Liu J; Ye L; Lin K; Zhong T; Luo J; Wang T; Suo L; Mo Q; Li S; Chen Q; Yu Y
    Mol Cell Biochem; 2023 Aug; 478(8):1727-1742. PubMed ID: 36565360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.
    Balsamo M; Manzini C; Pietra G; Raggi F; Blengio F; Mingari MC; Varesio L; Moretta L; Bosco MC; Vitale M
    Eur J Immunol; 2013 Oct; 43(10):2756-64. PubMed ID: 23913266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
    Xu LJ; Ma Q; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
    Mol Med Rep; 2018 Jun; 17(6):8111-8120. PubMed ID: 29693186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.
    Noman MZ; Janji B; Berchem G; Chouaib S
    Cancer Lett; 2016 Sep; 380(1):257-62. PubMed ID: 26523672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leveraging NKG2D Ligands in Immuno-Oncology.
    Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():713158. PubMed ID: 34394116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine Kinase 1 Acts as a Hypoxia-Upregulated Oncogene to Regulate Cell Invasion and Resistance to NK Cell Killing in Bladder Carcinoma Cells.
    Li L; Wang D; Xin S; Ren X; Zhang J
    Ann Clin Lab Sci; 2022 Sep; 52(5):763-771. PubMed ID: 36261193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-140-3p inhibits natural killer cytotoxicity to human ovarian cancer via targeting MAPK1.
    Wang J; Zhu M; Zhou X; Wang T; Xi Y; Jing Z; Xi W
    J Biosci; 2020; 45():. PubMed ID: 32385217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment.
    Abou Khouzam R; Rao SP; Venkatesh GH; Zeinelabdin NA; Buart S; Meylan M; Nimmakayalu M; Terry S; Chouaib S
    Front Immunol; 2021; 12():680435. PubMed ID: 34093582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
    Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
    Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity.
    Min D; Lv XB; Wang X; Zhang B; Meng W; Yu F; Hu H
    Br J Cancer; 2013 Aug; 109(3):723-30. PubMed ID: 23820258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.